Chronic traumatic encephalopathy: identifying those at risk and understanding pathogenesis

por Willis, M. D., Robertson, N. P.
Publicado 2017

Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease

por Willis, M. D., Robertson, N. P.
Publicado 2018

Correction to: Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease

por Willis, M. D., Robertson, N. P.
Publicado 2018

Neurotoxicity of novel cancer immunotherapies

por Willis, M. D., Robertson, N. P.
Publicado 2019

Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2

por Willis, M. D., Robertson, N. P.
Publicado 2020

Multiple sclerosis: early indicators of disease and assessing future risk

por Willis, M. D., Robertson, N. P.
Publicado 2020

Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies

por Beesley, R., Cauchi, M., Davies, L., Upcott, M., Norton, E., Loveless, S., Anderson, V., Wynford-Thomas, R., Pickersgill, T.P., Uzochukwu, E., Wardle, M., Robertson, N.P., Tallantyre, E., Willis, M.D.
Publicado 2022